Dr. Mersedeh Rohanizadegan, MD

Dr. Rohanizadegan practices at Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Rohanizadegan's NPI, 1639433220, was assigned on June 27, 2012. Dr. Rohanizadegan graduated from Tehran University of Medical Sciences School of Medicine in 2009. Dr. Rohanizadegan holds Pennsylvania license MD479123.

Dr. Rohanizadegan's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. The practice phone is (215) 615-4949.

Dr. Rohanizadegan's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dr. Rohanizadegan is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Rohanizadegan to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rohanizadegan practices, 4 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Rohanizadegan's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Rohanizadegan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rohanizadegan's licenses on file in 5 states: Pennsylvania, California, Massachusetts, New Hampshire and Maine.

CMS data shows 80 Medicare services from Dr. Rohanizadegan across 2 procedure codes in 2024, all of them office visits, for 88 Medicare patients. Medicare paid $10,388 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Dr. Rohanizadegan in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rohanizadegan's median patient age at 41, with 68% women.

Dr. Rohanizadegan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rohanizadegan as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Rohanizadegan, published from 2010 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Genetic Association Studies, Abnormalities, Multiple and Acetylation. Dr. Rohanizadegan has published most often in Am J Med Genet A. Dr. Rohanizadegan's most frequent co-authors are Natalia Gomez-Ospina, MD, Alicia M. Hinze, MD and Greysha Rivera-Cruz, MD.

CMS Open Payments shows 1 general payment to Dr. Rohanizadegan from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $120.

Dmand AI lists 2 awards for Dr. Rohanizadegan, most recently Honored tutor of Students' Scientific Research Center (SSRC) in 2005.

Dr. Rohanizadegan graduated from Tehran University of Medical Sciences School of Medicine in 2009.

Dr. Rohanizadegan is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.